scholarly journals Endovascular management of symptomatic deep vein thrombosis with combined approach

2021 ◽  
Vol 9 (9) ◽  
Author(s):  
Vito Gallicchio ◽  
Danilo Barbarisi ◽  
Rosaria Sciarrillo ◽  
Loris Flora
Keyword(s):  
Deep Vein Thrombosis ◽  
Combined Approach ◽  
Endovascular Management ◽  
Symptomatic Deep Vein Thrombosis ◽  
Vein Thrombosis ◽  
Deep Vein

scholarly journals Endovascular management of symptomatic Deep Vein Thrombosis (DVT) with Combined Approach

2021 ◽  
Author(s):  
Vito Gallicchio ◽  
Danilo Barbarisi ◽  
Rosaria SCIARRILLO ◽  
Loris Flora
Keyword(s):  
Leg Pain ◽  
Combined Approach ◽  
Endovascular Management ◽  
Endovascular Techniques ◽  
Venous Outflow ◽  
Skin Changes ◽  
Symptomatic Deep Vein Thrombosis ◽  
Vein Thrombosis ◽  
Deep Vein ◽  
Venous Claudication

The primary goal of this treatment is the restoration of venous outflow and can be achieved by combined endovascular techniques. We report a case of 38 years-old female, with leg pain and edema, skin changes, venous claudication and dyspnea for polmunary embolism.

scholarly journals Symptomatic Deep Vein Thrombosis Following Elective Knee Arthroscopy Over the Age of 40

2019 ◽  
Vol 25 ◽  
pp. 107602961985216 ◽  
Author(s):  
Mert Özcan ◽  
Murat Erem ◽  
Fatma Nesrin Turan
Keyword(s):  
Risk Factors ◽  
Deep Vein Thrombosis ◽  
Medical History ◽  
Symptomatic Deep Vein Thrombosis ◽  
Vein Thrombosis ◽  
Contraceptive Usage ◽  
Venous Thromboembolic Events ◽  
History Of ◽  
Deep Vein ◽  
Previous Medical History

Thromboprophylaxis following arthroscopic knee surgery (AKS) is not clear in the literature. The purpose of this study was to present the incidence of symptomatic deep vein thrombosis (DVT) following elective AKS over the age of 40. The secondary purpose was to investigate risk factors associated with venous thromboembolic events (VTEs). Surgical database and outpatient clinic follow-up charts of the patients who underwent AKS for any reason were included in the study. Odds for risk factors such as previous medical history of thrombosis, any family history for clotting disorders, diabetes mellitus (DM), oral contraceptive usage, body mass index, history of malignancy, and smoking were evaluated. The incidence of DVT following AKS significantly increased in the patients older than 40 years who had a previous medical history of VTE, DM, and smoking. A variety of guidelines exist for VTE prophylaxis; however, one should focus on risk factors related to the patient’s medical history and current medical conditions. In this study, smoking, DM, and previous history of DVT increased DVT risk significantly, and thromboprophylaxis should be kept in mind for these patients.

Metabolic Syndrome and the Incidence of Symptomatic Deep Vein Thrombosis Following Total Knee Arthroplasty

2009 ◽  
Vol 36 (10) ◽  
pp. 2298-2301 ◽  
Author(s):  
RAJIV GANDHI ◽  
FAHAD RAZAK ◽  
PEGGY TSO ◽  
J. RODERICK DAVEY ◽  
NIZAR N. MAHOMED
Keyword(s):  
Metabolic Syndrome ◽  
Deep Vein Thrombosis ◽  
Symptomatic Deep Vein Thrombosis ◽  
Joint Registry ◽  
Vein Thrombosis ◽  
Increased Risk ◽  
Total Knee ◽  
Prophylactic Anticoagulation ◽  
Relationship Of ◽  
Deep Vein

Objective.We asked if patients with metabolic syndrome undergoing total knee replacement (TKR) have an increased risk for symptomatic deep vein thrombosis (DVT) at 3 months followup.Methods.We reviewed 1460 patients from our joint registry undergoing primary, unilateral TKR between 1998–2006. Demographic variables of age, sex, comorbidity, and education were retrieved. Metabolic syndrome was defined as body mass index above 30 kg/m2, diabetes, hypertension, and hypercholesterolemia. Logistic regression was used to examine the relationship of metabolic syndrome on the incidence of DVT.Results.The overall incidence of symptomatic DVT was 4.4% (65/1460). Patients with metabolic syndrome had an increased incidence of DVT compared to those without metabolic syndrome (15.5% vs 3.4%). Adjusted analysis showed that the risk of symptomatic DVT in patients with metabolic syndrome was 3.2 times [odds ratio 3.2, 95% CI (1.0,15.4), p = 0.04] the risk in those without metabolic syndrome.Conclusion.Hospital protocols developed for prophylactic anticoagulation following TKR should give special consideration to patients with metabolic syndrome.

Sign in / Sign up

Export Citation Format

Share Document